1. Home
  2. BCYC vs CYH Comparison

BCYC vs CYH Comparison

Compare BCYC & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • CYH
  • Stock Information
  • Founded
  • BCYC 2009
  • CYH 1985
  • Country
  • BCYC United Kingdom
  • CYH United States
  • Employees
  • BCYC N/A
  • CYH N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • CYH Hospital/Nursing Management
  • Sector
  • BCYC Health Care
  • CYH Health Care
  • Exchange
  • BCYC Nasdaq
  • CYH Nasdaq
  • Market Cap
  • BCYC 566.5M
  • CYH 482.7M
  • IPO Year
  • BCYC 2019
  • CYH 1991
  • Fundamental
  • Price
  • BCYC $7.42
  • CYH $3.32
  • Analyst Decision
  • BCYC Buy
  • CYH Hold
  • Analyst Count
  • BCYC 10
  • CYH 8
  • Target Price
  • BCYC $25.00
  • CYH $4.27
  • AVG Volume (30 Days)
  • BCYC 223.0K
  • CYH 2.1M
  • Earning Date
  • BCYC 08-05-2025
  • CYH 07-23-2025
  • Dividend Yield
  • BCYC N/A
  • CYH N/A
  • EPS Growth
  • BCYC N/A
  • CYH N/A
  • EPS
  • BCYC N/A
  • CYH N/A
  • Revenue
  • BCYC $25,722,000.00
  • CYH $12,653,000,000.00
  • Revenue This Year
  • BCYC $7.35
  • CYH N/A
  • Revenue Next Year
  • BCYC N/A
  • CYH $3.49
  • P/E Ratio
  • BCYC N/A
  • CYH N/A
  • Revenue Growth
  • BCYC N/A
  • CYH 1.05
  • 52 Week Low
  • BCYC $6.10
  • CYH $2.24
  • 52 Week High
  • BCYC $28.67
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 36.14
  • CYH 44.49
  • Support Level
  • BCYC $8.33
  • CYH $3.01
  • Resistance Level
  • BCYC $8.63
  • CYH $3.27
  • Average True Range (ATR)
  • BCYC 0.50
  • CYH 0.19
  • MACD
  • BCYC -0.13
  • CYH -0.07
  • Stochastic Oscillator
  • BCYC 7.18
  • CYH 31.12

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: